hotspot -WSS

hotspot

author：knowledge 2025-10-02 22:58:30 - browse：41122

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Beach reads and more: STAT's 2023 summer book list

WSS

Diversify hospital leadership teams to protect BIPOC patient health

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

What to know about OceanGate, the company behind the missing Titanic submersible

MoonLake credibility takes another hit with mid

FDA approves Recor Medical high blood pressure device

Bulgari apologizes to China for listing Taiwan as a country after online backlash

entertainment

hotspot

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Removing probiotics from the NICU could threaten preemies' health

Cancer drug shortages should be causing more outrage

FDA approves potent Eli Lilly obesity drug, Zepbound

Heart attack and stroke risk calculators need revising

The new shift in health care is toward less care

Peter Hotez and the public health issue of online harassment

Retired US general questions alleged Putin, Prigozhin meeting

In Memoriam: Notable people who died in 2023

Senate panel clears PBM, hopsital reforms

knowledge

Bulgari apologizes to China for listing Taiwan as a country after online backlash

10 million people disenrolled from Medicaid over past six months

Extreme heat events are a public health emergency

New research casts further doubt on a common procedure used with IVF

N.Y. state detects polio case, first in the U.S. since 2013

A new study sees potential in DNA sequencing of infants

focus

explore

focus

focus